Assignee
LASSEN THERAPEUTICS INC
US·2 granted patents·3 pending applications·0 citations·filing 2024–2025
Top patents by PatentIndex Score
5 records- 0182US12365738B2Method of treating an interleukin-11-associated or -mediated fibrotic disease or condition by administering an anti-interleukin-11 receptor subunit alpha (IL-11RA) antibodyLASSEN THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·0 cites·16 claims
- 0279US2026008858A1Anti-interleukin-11 receptor subunit alpha (il-11ra) antibodiesLASSEN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0379US2025368746A1Method of treating diseases or conditions by administering an anti-interleukin-11 receptor subunit alpha (il-11ra) antibodyLASSEN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0465US12365737B2Anti-IL-18BP antibodiesLASSEN THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·0 cites·25 claims
- 0555US2025368745A1Anti-il 18bp antibodiesLASSEN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LASSEN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →